Janssen Agrees With Creation Of Invokana MDL, Transfer To New Jersey
WASHINGTON, D.C. — Janssen Pharmaceuticals Inc. on Oct. 12 said it agrees with some plaintiffs that at least 57 federal lawsuits alleging kidney failure or ketoacidosis from the diabetes drug Invokana...To view the full article, register now.
Already a subscriber? Click here to view full article